Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of dienogest in reducing dysmenorrhea
IRCT20150105020558N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dienogest in dysmenorrhea, sponsored by Tehran University of Medical Sciences. Started Oct 2022; status: completed.
02
Drugs
dienogest
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on IRCT20150105020558N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150105020558N5.